BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 23832962)

  • 41. Effect of voluntary exercise on peripheral tissue glucocorticoid receptor content and the expression and activity of 11beta-HSD1 in the Syrian hamster.
    Coutinho AE; Campbell JE; Fediuc S; Riddell MC
    J Appl Physiol (1985); 2006 May; 100(5):1483-8. PubMed ID: 16357069
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antidiabetic effects of 11beta-HSD1 inhibition in a mouse model of combined diabetes, dyslipidaemia and atherosclerosis.
    Lloyd DJ; Helmering J; Cordover D; Bowsman M; Chen M; Hale C; Fordstrom P; Zhou M; Wang M; Kaufman SA; Véniant MM
    Diabetes Obes Metab; 2009 Jul; 11(7):688-99. PubMed ID: 19527482
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vertical sleeve gastrectomy normalizes circulating glucocorticoid levels and lowers glucocorticoid action tissue-selectively in mice.
    Akalestou E; Lopez-Noriega L; Christakis I; Hu M; Miras AD; Leclerc I; Rutter GA
    Front Endocrinol (Lausanne); 2022; 13():1020576. PubMed ID: 36246869
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice.
    Paterson JM; Morton NM; Fievet C; Kenyon CJ; Holmes MC; Staels B; Seckl JR; Mullins JJ
    Proc Natl Acad Sci U S A; 2004 May; 101(18):7088-93. PubMed ID: 15118095
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vitamin A decreases pre-receptor amplification of glucocorticoids in obesity: study on the effect of vitamin A on 11beta-hydroxysteroid dehydrogenase type 1 activity in liver and visceral fat of WNIN/Ob obese rats.
    Sakamuri VP; Ananthathmakula P; Veettil GN; Ayyalasomayajula V
    Nutr J; 2011 Jun; 10():70. PubMed ID: 21696642
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Local cortisol/corticosterone activation in skin physiology and pathology.
    Terao M; Katayama I
    J Dermatol Sci; 2016 Oct; 84(1):11-16. PubMed ID: 27431412
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects.
    Alberti L; Girola A; Gilardini L; Conti A; Cattaldo S; Micheletto G; Invitti C
    Int J Obes (Lond); 2007 Dec; 31(12):1826-31. PubMed ID: 17593901
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Correlations between the hypothalamo-pituitary-adrenal axis and the metabolic syndrome].
    Góth M; Hubina E; Korbonits M
    Orv Hetil; 2005 Jan; 146(2):51-5. PubMed ID: 15724952
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulation of glucocorticoid sensitivity in thymocytes from burn-injured mice.
    D'Elia M; Patenaude J; Bernier J
    Am J Physiol Endocrinol Metab; 2009 Jan; 296(1):E97-104. PubMed ID: 19001548
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased glucocorticoid receptor and 11{beta}-hydroxysteroid dehydrogenase type 1 expression in hepatocytes may contribute to the phenotype of type 2 diabetes in db/db mice.
    Liu Y; Nakagawa Y; Wang Y; Sakurai R; Tripathi PV; Lutfy K; Friedman TC
    Diabetes; 2005 Jan; 54(1):32-40. PubMed ID: 15616008
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tissue specific regulation of glucocorticoids in severe obesity and the response to significant weight loss following bariatric surgery (BARICORT).
    Woods CP; Corrigan M; Gathercole L; Taylor A; Hughes B; Gaoatswe G; Manolopoulos K; Hogan AE; O'Connell J; Stewart PM; Tomlinson JW; O'Shea D; Sherlock M
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1434-44. PubMed ID: 25603461
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel highly potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, UI-1499.
    Byun SY; Shin YJ; Nam KY; Hong SP; Ahn SK
    Life Sci; 2015 Jan; 120():1-7. PubMed ID: 25447448
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase in adipose tissue.
    Seckl JR; Morton NM; Chapman KE; Walker BR
    Recent Prog Horm Res; 2004; 59():359-93. PubMed ID: 14749510
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Down-regulation of adipose 11beta-hydroxysteroid dehydrogenase type 1 by high-fat feeding in mice: a potential adaptive mechanism counteracting metabolic disease.
    Morton NM; Ramage L; Seckl JR
    Endocrinology; 2004 Jun; 145(6):2707-12. PubMed ID: 15044372
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduced 11beta-hydroxysteroid dehydrogenase type 1 activity in obese boys.
    Wiegand S; Richardt A; Remer T; Wudy SA; Tomlinson JW; Hughes B; Grüters A; Stewart PM; Strasburger CJ; Quinkler M
    Eur J Endocrinol; 2007 Sep; 157(3):319-24. PubMed ID: 17766714
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo activity of 11β-hydroxysteroid dehydrogenase type 1 in man: effects of prednisolone and chenodesoxycholic acid.
    Diederich S; Quinkler M; Mai K; Schöneshöfer M; Baehr V; Pfeiffer A; Oelkers W; Eigendorff E
    Horm Metab Res; 2011 Jan; 43(1):66-71. PubMed ID: 20925019
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of 11β-hydroxysteroid dehydrogenase 1 by carbenoxolone affects glucose homeostasis and obesity in db/db mice.
    Dhanesha N; Joharapurkar A; Shah G; Kshirsagar S; Dhote V; Sharma A; Jain M
    Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):69-77. PubMed ID: 22060140
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 11β-Hydroxysteroid dehydrogenase type 1 selective inhibitor BVT.2733 protects osteoblasts against endogenous glucocorticoid induced dysfunction.
    Wu L; Qi H; Zhong Y; Lv S; Yu J; Liu J; Wang L; Bi J; Kong X; Di W; Zha J; Liu F; Ding G
    Endocr J; 2013; 60(9):1047-58. PubMed ID: 23759754
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors still improve metabolic phenotype in male 11β-HSD1 knockout mice suggesting off-target mechanisms.
    Harno E; Cottrell EC; Yu A; DeSchoolmeester J; Gutierrez PM; Denn M; Swales JG; Goldberg FW; Bohlooly-Y M; Andersén H; Wild MJ; Turnbull AV; Leighton B; White A
    Endocrinology; 2013 Dec; 154(12):4580-93. PubMed ID: 24169553
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The 11β-hydroxysteroid dehydrogenase type 1 inhibitor protects against the insulin resistance and hepatic steatosis in db/db mice.
    Yuan X; Li H; Bai H; Zhao X; Zhang C; Liu H; Zhang Y; Zhao B; Wu Y; Liu J; Xiang Q; Feng B; Chu Y; Huang Y
    Eur J Pharmacol; 2016 Oct; 788():140-151. PubMed ID: 27242185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.